hrt and glp-1 A recent study from 2024 found that enhances weight loss in postmenopausal women who are also on a by about 4% weight loss at 12 months compared to those not Did you know women in

Description

Human retinal organoids and patient-derived cell lines could bridge this gap by providing disease-relevant platforms for mechanistic interrogation

With regard to this, the recently published FLOW study (Perkovic V, et al

SeekPeptides members have been asking these questions for months, and the answers are more interesting than you might expect

Breast augmentation has turned positive year over year for the first time since 2021 in the last two quarters, perhaps attributable to the wealth effect (I dont believe this is yet attributable to GLP-1s, although future growth against the easy comps of 1H 23 may be): The largest players in the breast implant space are JNJ & ABBV , but they are definitively and obviously not pure plays

Other considerations include if this class of medications is dropped from coverage, patients on the drugs will need to find other ways to pay for it if they want to continue, the affordability and availability of the medications, and what will the long-term impact be if patients stop taking the medications suddenly